Alvis, Bret D.
Polcz, Monica http://orcid.org/0000-0001-8744-5982
Miles, Merrick
Wright, Donald
Shwetar, Mohammad
Leisy, Phil
Forbes, Rachel
Fissell, Rachel
Whitfield, Jon
Eagle, Susan
Brophy, Colleen
Hocking, Kyle
Funding for this research was provided by:
National Science Foundation (1549576)
Article History
Received: 24 April 2019
Accepted: 8 May 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: This study was performed in accordance with the Vanderbilt University Medical Center Institutional Review Board and due to potential institutional conflicts, the University of Alabama Institutional Review Board. Written documented informed consent was obtained from all subjects enrolled in the study.
: Not applicable.
: Kyle Hocking, PhD, is Founder, CEO and President of VoluMetrix and an inventor on intellectual property in the field of venous waveform analysis assigned to Vanderbilt and licensed to VoluMetrix. Colleen Brophy, MD, is Founder and CMO of VoluMetrix and an inventor on intellectual property in the field of venous waveform analysis assigned to Vanderbilt and licensed to VoluMetrix. Jon Whitfield, ME is an engineer and owns stock with VoluMetrix. Bret Alvis, MD, owns stock in VoluMetrix and an inventor on intellectual property in the field of venous waveform analysis assigned to Vanderbilt and licensed to VoluMetrix and is married to the COO of VoluMetrix. Susan Eagle, MD is former founder and CEO of Volumetrix and an inventor on intellectual property in the field of venous waveform analysis assigned to Vanderbilt and licensed to Volumetrix.